Literature DB >> 16260390

Molecular and cellular mechanisms of neuronal cell death in HIV dementia.

W Li1, D Galey, M P Mattson, A Nath.   

Abstract

The deaths of neurons, astrocytes and endothelial cells have been described in patients with HIV (human immunodeficiency virus) dementia. HIV-1 does not infect neurons; instead, neurotoxic substances shed by infected glia and macrophages can induce a form of programmed cell death called apoptosis in neurons. These neurotoxins include the HIV-1 proteins Tat and gp120, as well as pro-inflammatory cytokines, chemokines, excitotoxins and proteases. In this article we review the evidence for apoptosis of various cell types within the brain of HIV-infected patients, and describe in vitro and in vivo experimental studies that have elucidated the mechanisms by which HIV causes apoptosis of brain cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260390     DOI: 10.1007/bf03033824

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  230 in total

1.  Integrin signaling via the PI3-kinase-Akt pathway increases neuronal resistance to glutamate-induced apoptosis.

Authors:  D S Gary; M P Mattson
Journal:  J Neurochem       Date:  2001-03       Impact factor: 5.372

Review 2.  NF-kappaB in neuronal plasticity and neurodegenerative disorders.

Authors:  M P Mattson; S Camandola
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

3.  HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region.

Authors:  H C Chang; F Samaniego; B C Nair; L Buonaguro; B Ensoli
Journal:  AIDS       Date:  1997-10       Impact factor: 4.177

4.  Amelioration of neurotoxic effects of HIV envelope protein gp120 by fibroblast growth factor: a strategy for neuroprotection.

Authors:  I P Everall; G Trillo-Pazos; C Bell; M Mallory; V Sanders; E Masliah
Journal:  J Neuropathol Exp Neurol       Date:  2001-03       Impact factor: 3.685

5.  Cerebrospinal fluid nitrite/nitrate levels in neurologic diseases.

Authors:  S Milstien; N Sakai; B J Brew; C Krieger; J H Vickers; K Saito; M P Heyes
Journal:  J Neurochem       Date:  1994-09       Impact factor: 5.372

Review 6.  Cell death: the significance of apoptosis.

Authors:  A H Wyllie; J F Kerr; A R Currie
Journal:  Int Rev Cytol       Date:  1980

7.  HIV-1 Tat-mediated inhibition of the tyrosine hydroxylase gene expression in dopaminergic neuronal cells.

Authors:  G Zauli; P Secchiero; L Rodella; D Gibellini; P Mirandola; M Mazzoni; D Milani; D R Dowd; S Capitani; M Vitale
Journal:  J Biol Chem       Date:  2000-02-11       Impact factor: 5.157

8.  Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.

Authors:  Bénédicte Puissant; Michel Abbal; Antoine Blancher
Journal:  Immunogenetics       Date:  2003-07-23       Impact factor: 2.846

9.  Inducible nitric oxide synthase is involved in the mechanisms of cocaine enhanced neuronal apoptosis induced by HIV-1 gp120 in the neocortex of rat.

Authors:  G Bagetta; S Piccirilli; C Del Duca; L A Morrone; L Rombolà; G Nappi; J De Alba; R G Knowles; M T Corasaniti
Journal:  Neurosci Lett       Date:  2004-02-19       Impact factor: 3.046

10.  Regulation of nitric oxide synthase activity in human immunodeficiency virus type 1 (HIV-1)-infected monocytes: implications for HIV-associated neurological disease.

Authors:  M I Bukrinsky; H S Nottet; H Schmidtmayerova; L Dubrovsky; C R Flanagan; M E Mullins; S A Lipton; H E Gendelman
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more
  50 in total

1.  Effect of host genetics on incidence of HIV neuroretinal disorder in patients with AIDS.

Authors:  Efe Sezgin; Sher L Hendrickson; Douglas A Jabs; Mark L Van Natta; Richard A Lewis; Jennifer L Troyer; Stephen J O'Brien
Journal:  J Acquir Immune Defic Syndr       Date:  2010-08       Impact factor: 3.731

Review 2.  Neurocognitive impairment and HIV risk factors: a reciprocal relationship.

Authors:  Pria Anand; Sandra A Springer; Michael M Copenhaver; Frederick L Altice
Journal:  AIDS Behav       Date:  2010-12

Review 3.  Rodent models for HIV-associated neurocognitive disorders.

Authors:  Santhi Gorantla; Larisa Poluektova; Howard E Gendelman
Journal:  Trends Neurosci       Date:  2012-02-01       Impact factor: 13.837

4.  Neuroprotective activity of pDING in response to HIV-1 Tat.

Authors:  Nune Darbinian; Kamel Khalili; Shohreh Amini
Journal:  J Cell Physiol       Date:  2014-02       Impact factor: 6.384

5.  Regional cortical thinning associated with detectable levels of HIV DNA.

Authors:  Kalpana J Kallianpur; Gregory R Kirk; Napapon Sailasuta; Victor Valcour; Bruce Shiramizu; Beau K Nakamoto; Cecilia Shikuma
Journal:  Cereb Cortex       Date:  2011-10-19       Impact factor: 5.357

Review 6.  Mechanisms of HIV-1 Tat neurotoxicity via CDK5 translocation and hyper-activation: role in HIV-associated neurocognitive disorders.

Authors:  Jerel Adam Fields; Wilmar Dumaop; Leslie Crews; Anthony Adame; Brian Spencer; Jeff Metcalf; Johnny He; Edward Rockenstein; Eliezer Masliah
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

7.  EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.

Authors:  Brian Giunta; Demian Obregon; Hauyan Hou; Jin Zeng; Nan Sun; Veljko Nikolic; Jared Ehrhart; Douglas Shytle; Francisco Fernandez; Jun Tan
Journal:  Brain Res       Date:  2006-10-31       Impact factor: 3.252

Review 8.  Apoptosis in animal models of virus-induced disease.

Authors:  Penny Clarke; Kenneth L Tyler
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

9.  Neuronal toxicity in HIV CNS disease.

Authors:  Jane Kovalevich; Dianne Langford
Journal:  Future Virol       Date:  2012-07-01       Impact factor: 1.831

10.  HIV-1 clade-specific differences in the induction of neuropathogenesis.

Authors:  Vasudev R Rao; Andrew R Sas; Eliseo A Eugenin; Nagadenahalli B Siddappa; Heather Bimonte-Nelson; Joan W Berman; Udaykumar Ranga; William R Tyor; Vinayaka R Prasad
Journal:  J Neurosci       Date:  2008-10-01       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.